688068 熱景生物
按盤價 
30.120 +3.560 (+13.404%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -1.323 | 0.817 | 30.580 | 121.897 | 16.150 |
| 總資產報酬率 ROA (%) | -1.252 | 0.733 | 25.046 | 96.133 | 13.766 |
| 投入資產回報率 ROIC (%) | -1.310 | 0.799 | 28.652 | 111.849 | 13.971 | 邊際利潤分析 |
| 銷售毛利率 (%) | 49.976 | 56.953 | 53.711 | 59.538 | 63.012 |
| 營業利潤率 (%) | -16.906 | 3.180 | 30.672 | 48.134 | 24.916 |
| 息稅前利潤/營業總收入 (%) | -23.287 | -5.409 | 29.290 | 48.151 | 24.514 |
| 淨利潤/營業總收入 (%) | -18.352 | 2.781 | 26.012 | 41.019 | 21.673 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 108.296 | -355.323 | 117.095 | 102.716 | 90.402 |
| 價值變動淨收益/利潤總額(%) | -0.079 | -165.228 | 1.015 | 0.964 | 6.378 |
| 營業外收支淨額/利潤總額(%) | 2.342 | -27.437 | -1.454 | -0.101 | -0.413 | 償債能力分析 |
| 流動比率 (X) | 6.881 | 4.457 | 3.517 | 3.429 | 4.079 |
| 速動比率 (X) | 6.080 | 3.731 | 3.215 | 3.077 | 3.202 |
| 資產負債率 (%) | 4.941 | 5.768 | 13.992 | 21.154 | 17.254 |
| 帶息債務/全部投入資本 (%) | 0.080 | 0.757 | 2.153 | 8.587 | -- |
| 股東權益/帶息債務 (%) | 123,773.908 | 13,046.365 | 4,497.771 | 1,050.889 | 23,935.860 |
| 股東權益/負債合計 (%) | 1,923.622 | 1,634.569 | 611.307 | 368.803 | 476.954 |
| 利息保障倍數 (X) | 3.897 | 0.684 | -31.106 | 738.811 | -81.991 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 29.993 | 41.101 | 6.727 | 2.139 | 0.000 |
| 存貨周轉天數 (天) | 184.485 | 224.879 | 45.142 | 31.893 | 0.000 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
